| Primary |
| Premature Labour |
26.1% |
| Asthma |
17.4% |
| Premature Labor |
8.7% |
| Uterine Contractions During Pregnancy |
8.7% |
| Dyspnea |
4.3% |
| Labor Premature |
4.3% |
| Labour Induction |
4.3% |
| Maternal Exposure During Pregnancy |
4.3% |
| Pain |
4.3% |
| Premature Uterine Contractions |
4.3% |
| Status Asthmaticus |
4.3% |
| Uterine Contractions Abnormal |
4.3% |
| Uterine Disorder |
4.3% |
|
| Anxiety |
5.0% |
| Arrhythmia |
5.0% |
| Blood Pressure Increased |
5.0% |
| Educational Problem |
5.0% |
| Electrocardiogram St Segment Abnormal |
5.0% |
| Foetal Death |
5.0% |
| Heart Rate Increased |
5.0% |
| Hypoaesthesia |
5.0% |
| Hypotension |
5.0% |
| Lactic Acidosis |
5.0% |
| Malaise |
5.0% |
| Myocardial Infarction |
5.0% |
| Partial Seizures |
5.0% |
| Postictal State |
5.0% |
| Premature Labour |
5.0% |
| Respiratory Arrest |
5.0% |
| Restlessness |
5.0% |
| Speech Disorder Developmental |
5.0% |
| Status Epilepticus |
5.0% |
| Stress Cardiomyopathy |
5.0% |
|
| Secondary |
| Foetal Exposure During Pregnancy |
31.7% |
| Product Used For Unknown Indication |
24.3% |
| Asthma |
13.8% |
| Bipolar Disorder |
4.9% |
| Maternal Exposure Timing Unspecified |
3.6% |
| Influenza |
2.7% |
| Premature Labour |
2.7% |
| Pregnancy |
2.2% |
| Lung Disorder |
1.8% |
| Bacterial Infection |
1.6% |
| Anxiety |
1.3% |
| Psoriatic Arthropathy |
1.3% |
| Urinary Tract Infection |
1.3% |
| Agitation |
1.1% |
| Contraception |
1.1% |
| Ear Infection |
0.9% |
| H1n1 Influenza |
0.9% |
| Headache |
0.9% |
| Psoriasis |
0.9% |
| Respiratory Distress |
0.9% |
|
| Lactic Acidosis |
15.0% |
| Speech Disorder |
12.5% |
| Meningitis Aseptic |
7.5% |
| Aggression |
5.0% |
| Asthma |
5.0% |
| Deafness Bilateral |
5.0% |
| Maternal Exposure During Pregnancy |
5.0% |
| Maternal Exposure Timing Unspecified |
5.0% |
| Premature Delivery |
5.0% |
| Renal Tubular Necrosis |
5.0% |
| Respiratory Distress |
5.0% |
| Restlessness |
5.0% |
| Abortion Spontaneous |
2.5% |
| Anxiety |
2.5% |
| Bipolar Disorder |
2.5% |
| Bradycardia |
2.5% |
| Burns Second Degree |
2.5% |
| Cardioversion |
2.5% |
| Confusional State |
2.5% |
| Cough |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
44.1% |
| Asthma |
9.8% |
| Chronic Obstructive Pulmonary Disease |
4.1% |
| Prophylaxis |
4.1% |
| Depression |
3.9% |
| Hypersensitivity |
3.9% |
| Pain |
3.9% |
| Insomnia |
2.8% |
| Dyspepsia |
2.7% |
| Premature Labour |
2.7% |
| Crohn's Disease |
2.2% |
| Nausea |
2.1% |
| Follicle-stimulating Hormone Deficiency |
2.0% |
| Smoking Cessation Therapy |
2.0% |
| Rheumatoid Arthritis |
1.7% |
| Anxiety |
1.6% |
| Drug Use For Unknown Indication |
1.6% |
| Hypogonadism |
1.6% |
| Ovarian Disorder |
1.6% |
| Pulmonary Arterial Hypertension |
1.5% |
|
| Thrombocytopenia |
9.9% |
| Withdrawal Syndrome |
9.9% |
| Polydactyly |
6.3% |
| Complex Partial Seizures |
5.4% |
| Testicular Pain |
5.4% |
| Ventricular Septal Defect |
5.4% |
| Vomiting |
5.4% |
| Balanitis |
4.5% |
| Craniosynostosis |
4.5% |
| Dysphagia |
4.5% |
| Epilepsy |
4.5% |
| Lactic Acidosis |
4.5% |
| Renal Failure |
4.5% |
| Drug Exposure During Pregnancy |
3.6% |
| Drug Toxicity |
3.6% |
| Gastric Perforation |
3.6% |
| Oesophageal Spasm |
3.6% |
| Pneumonia |
3.6% |
| Premature Baby |
3.6% |
| Premature Labour |
3.6% |
|
